Is Your Site Gene Therapy Ready™

Research into gene therapy-based treatments and mRNA-based vaccines is accelerating exponentially. Is your research site ready to support this growing field?

Save five to six weeks off your study activation by joining the Gene Therapy Network.

Benefits include:

• Complimentary IBC registration with NIH Office of Science Policy so Advarra can serve as your site's IBC of record 
• Preferred site selection with sponsor/CRO when Advarra is the central IRB and IBC
• Documentation demonstrating to the sponsor/CRO your site can rapidly start the trial

Plus: Ask about our "Highlighted Site" offering to receive additional exposure and attract more studies.

To get started, submit the form to request Advarra's IBC registration form.